PAI Partners exits Amplitude Surgical in deal with Zydus
PAI Partners exits Amplitude Surgical in deal with Zydus
Amplitude Surgical, a specialist in lower-limb orthopedic technology, has seen significant growth under PAI’s ownership. Since acquiring the business through its Mid-Market Fund, PAI has helped Amplitude expand internationally, enhance manufacturing capabilities, and develop an innovative surgical robot. In fiscal 2024, Amplitude posted €106m in revenue and €27.1m in EBITDA.
“Amplitude has transformed into a European leader in lower-limb orthopedics, and this exit reflects the success of our growth strategy,” said Stefano Drago, Founding Partner at PAI Mid-Market Fund. The firm streamlined operations, divested non-core assets, and strengthened Amplitude’s R&D pipeline during its tenure.
Zydus sees the acquisition as a strategic expansion into MedTech. CEO and founder Olivier Jallabert, who will remain involved post-transaction, described the deal as “a testament to Amplitude’s success and resilience.”
The sale remains subject to regulatory approvals, including clearance from the French Minister of Economy. A subsequent tender offer by Zydus is expected to follow once the transaction closes, likely by June 2025.
Source: PAI Partners
If you think we missed any important news, please do not hesitate to contact us at news@pe-insights.com.